Treatment of neurodegenerative and cardiovascular disorders

A method of treating Parkinson's disease, heart failure, or cardiomyopathy, comprising administering to a subject in need thereof an effective amount of a compound of the following formula:

• in which
• each of R1 and R2, independently, is C1-8 alkylene, C2-8 alkenylene, or deleted;
• each of A1 and A2, independently, is aryl or heteroaryl, optionally substituted with halogen, —CN, —NO2, —OH, —SH, —OR3, —SR3, —R3, —R3—OR4, —C(O)R3, —S(O)R3, —S(O)2R3, —NR4R5, —C(O)OR3, —C(O)NR4R5, —O(O)CR4, or —NR4(O)CR5;
• and
• each of X and Y, independently, is O, S, or NR6;
• wherein each R3 is C1-4 alkyl, and each of R4, R5, and R6, independently, is H or C1-4 alkyl.